Medicoeconomic analysis of lobectomy using thoracoscopy versus thoracotomy for lung cancer: a study protocol for a multicentre randomised controlled trial (Lungsco01).

Fiche publication

Date publication

juin 2017

Journal

BMJ open

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BERNARD Alain , Pr FALCOZ Pierre-Emmanuel , Dr PAGES Pierre-Benoit

Tous les auteurs :
Pagès PB, Abou Hanna H, Bertaux AC, Serge Aho LS, Magdaleinat P, Baste JM, Filaire M, de Latour R, Assouad J, Tronc F, Jayle C, Mouroux J, Thomas PA, Falcoz PE, Marty-Ané CH, Bernard A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28619764

Résumé

In the last decade, video-assisted thoracoscopic surgery (VATS) lobectomy for non-small cell lung cancer (NSCLC) has had a major effect on thoracic surgery. Retrospective series have reported benefits of VATS when compared with open thoracotomy in terms of postoperative pain, postoperative complications and length of hospital stay. However, no large randomised control trial has been conducted to assess the reality of the potential benefits of VATS lobectomy or its medicoeconomic impact.